Pancreatic Cancer Research

ResearcherSaga UniversityActive in the last 2 years

Hirokazu Noshirο

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3227-7816; OpenAlex author ID A5011445856. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospecti… Co-author DOI 10.1002/ags3.70090↗
  2. A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arte… Co-author DOI 10.1245/s10434-022-12566-1↗
  3. Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Mult… Co-author DOI 10.29337/ijsp.142↗
  4. Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study. Co-author DOI 10.1007/s00423-019-01754-5↗
  5. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination]. Last author PMID 24917019↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susumu Eguchi · 4 shared papers, 2019–2026 · strength 0.57
  2. Toru Hisaka · 2 shared papers, 2023–2026 · strength 0.37
  3. Naoki Ikenaga · 2 shared papers, 2023–2026 · strength 0.37
  4. Kazuyoshi Nishihara · 3 shared papers, 2019–2023 · strength 0.34
  5. Masafumi Inomata · 3 shared papers, 2019–2023 · strength 0.34
  6. Yoshihiro Miyasaka · 3 shared papers, 2019–2023 · strength 0.34
  7. Takao Ohtsuka · 3 shared papers, 2019–2023 · strength 0.34
  8. Masafumi Nakamura · 2 shared papers, 2019–2026 · strength 0.30
  9. Hiroaki Nagano · 2 shared papers, 2019–2026 · strength 0.30
  10. Hiroaki Nagano · 2 shared papers, 2021–2023 · strength 0.27
  11. Masafumi Nakamura · 2 shared papers, 2021–2023 · strength 0.27
  12. Yasuhisa Mori · 1 shared paper, 2026 · strength 0.23
  13. Teijiro Hirashita · 1 shared paper, 2026 · strength 0.23
  14. Hiromitsu Hayashi · 1 shared paper, 2026 · strength 0.23
  15. Tomoharu Yoshizumi · 1 shared paper, 2026 · strength 0.23
  16. Hiroto Matsui Matsui · 1 shared paper, 2026 · strength 0.23
  17. Shingo Kozono · 1 shared paper, 2026 · strength 0.23
  18. Hirohisa Okabe · 1 shared paper, 2026 · strength 0.23
  19. Hiroshi Kurahara · 2 shared papers, 2019–2023 · strength 0.22
  20. Hideo Baba · 2 shared papers, 2019–2023 · strength 0.22
  21. Kousei Ishigami · 1 shared paper, 2023 · strength 0.15
  22. Kohei Nakata · 1 shared paper, 2023 · strength 0.15
  23. Hideo Baba · 1 shared paper, 2021 · strength 0.12
  24. Taketo Matsunaga · 1 shared paper, 2019 · strength 0.07
  25. Akira Chikamoto · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.